Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection74

Select a period of time:

Views

Views
September 20254
October 20252
November 20256
December 20254
January 20267
February 20260
March 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Finland5
Brazil5
United Kingdom3
Ecuador2
Austria1
Kenya1
Mexico1
Paraguay1
 

Top cities views

Views
Helsinki5
Dallas2
Araruama1
Ashburn1
Asunción1
Cuenca1
Guayaquil1
Iztacalco1
Mãe do Rio1
Nairobi1